melanoma updates from asco 2023: pd-1 and lag-3
Published 9 months ago • 357 plays • Length 10:02Download video MP4
Download video MP3
Similar videos
-
1:36:15
melanoma updates from asco 2023 symposium
-
3:12
asco 2021 highlights on anti lag3 in advanced melanoma the relativity 047 study
-
6:50
asco 2023 melanoma & skin cancer highlights with prof elizabeth buchbinder
-
24:21
asco melanoma update | karl lewis, md | 2022 review and renew sedona
-
3:26
post adjuvant pd-1 analysis of fianlimab and cemiplimab in melanoma
-
2:49
emerging melanoma therapeutics: ido1, lag-3 & hdac inhibitors
-
27:01
51. asco 2023 - melanoma & head and neck
-
59:56
melanoma highlights from asco
-
2:59
lag-3 antibody combination in immunotherapy-treated melanoma
-
1:02:27
asco 2024: advances in melanoma and related cancers
-
59:45
melanoma highlights from asco 2020
-
7:44
new data for melanoma patients who progress after pd-1 blockade
-
1:02
asco 2023: dr. jonathan zager
-
3:22
clinical activity of fianlimab, an anti-lag-3 mab combined with cemiplimab in advanced melanoma
-
1:23
immunotherapy at asco 2023: updates in neoadjuvant and adjuvant therapy
-
1:02:27
asco 2024: advances in melanoma and related cancers
-
14:39
asco guideline recommendation highlights for systemic therapy for melanoma
-
0:20
lung cancer trial updates at asco 2023